Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sing-Arm, Open Clinical Pharmacology Study of Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

NCT05387226 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Bengbu Medical University as lead sponsor.

NCT NCT05387226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05387226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sing-Arm, Open Clinical Pharmacology Study of Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma
Lead sponsor
The First Affiliated Hospital of Bengbu Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
May 31, 2022
Completion date
December 31, 2023
Enrollment
6 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intravenous injection, t-cell lymphoma, virus